Hulidar, Farhan B.
HRN: 27-25-59 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2025
MUPIROCIN 2%, 15G (TUBE)
06/07/2025
06/13/2025
TOPICAL
2%
BID
Infiltrated IV Site
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes